BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 38544689)

  • 21. Circular RNA circ_0008274 enhances the malignant progression of papillary thyroid carcinoma via modulating solute carrier family 7 member 11 by sponging miR-154-3p.
    Ma J; Kan Z
    Endocr J; 2021 May; 68(5):543-552. PubMed ID: 33473055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic regulation of papillary thyroid carcinoma by long non-coding RNAs.
    Lin RX; Yang SL; Jia Y; Wu JC; Xu Z; Zhang H
    Semin Cancer Biol; 2022 Aug; 83():253-260. PubMed ID: 33785446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Silencing of Long Non-coding RNA ENST00000606790.1 Inhibits the Malignant Behaviors of Papillary Thyroid Carcinoma through the PI3K/AKT Pathway.
    Zuo Z; Liu L; Song B; Tan J; Ding D; Lu Y
    Endocr Res; 2021 Feb; 46(1):1-9. PubMed ID: 32791924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CircLDLR Promotes Papillary Thyroid Carcinoma Tumorigenicity by Regulating miR-637/LMO4 Axis.
    Jiang YM; Liu W; Jiang L; Chang H
    Dis Markers; 2021; 2021():3977189. PubMed ID: 34925640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circular RNA Pvt1 oncogene (CircPVT1) promotes the progression of papillary thyroid carcinoma by activating the Wnt/β-catenin signaling pathway and modulating the ratio of microRNA-195 (miR-195) to vascular endothelial growth factor A (VEGFA) expression.
    Zeng L; Yuan S; Zhou P; Gong J; Kong X; Wu M
    Bioengineered; 2021 Dec; 12(2):11795-11810. PubMed ID: 34927541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circ_100395 impedes malignancy and glycolysis in papillary thyroid cancer: Involvement of PI3K/AKT/mTOR signaling pathway.
    Chen L; Zhuo D; Yuan H
    Immunol Lett; 2022 Jun; 246():10-17. PubMed ID: 35447227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular Network-Based Identification of Circular RNA-Associated ceRNA Network in Papillary Thyroid Cancer.
    Liu Q; Pan LZ; Hu M; Ma JY
    Pathol Oncol Res; 2020 Apr; 26(2):1293-1299. PubMed ID: 31289996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hsa_circ_0039411 promotes tumorigenesis and progression of papillary thyroid cancer by miR-1179/ABCA9 and miR-1205/MTA1 signaling pathways.
    Yang Y; Ding L; Li Y; Xuan C
    J Cell Physiol; 2020 Feb; 235(2):1321-1329. PubMed ID: 31270819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. circ_0005273 promotes thyroid carcinoma progression by SOX2 expression.
    Zhang W; Zhang H; Zhao X
    Endocr Relat Cancer; 2020 Jan; 27(1):11-21. PubMed ID: 31693489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. circFAT1(e2) Promotes Papillary Thyroid Cancer Proliferation, Migration, and Invasion via the miRNA-873/ZEB1 Axis.
    Liu J; Li H; Wei C; Ding J; Lu J; Pan G; Mao A
    Comput Math Methods Med; 2020; 2020():1459368. PubMed ID: 33133224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hsa_circRNA_102002 facilitates metastasis of papillary thyroid cancer through regulating miR-488-3p/HAS2 axis.
    Zhang W; Liu T; Li T; Zhao X
    Cancer Gene Ther; 2021 Apr; 28(3-4):279-293. PubMed ID: 32862195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Silencing circRNA protein kinase C iota (circ-PRKCI) suppresses cell progression and glycolysis of human papillary thyroid cancer through circ-PRKCI/miR-335/E2F3 ceRNA axis.
    Liu Y; Chen G; Wang B; Wu H; Zhang Y; Ye H
    Endocr J; 2021 Jun; 68(6):713-727. PubMed ID: 33716239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. circ-PSD3 promoted proliferation and invasion of papillary thyroid cancer cells via regulating the miR-7-5p/METTL7B axis.
    Zhu J; Wang Y; Yang C; Feng Z; Huang Y; Liu P; Chen F; Deng Z
    J Recept Signal Transduct Res; 2022 Jun; 42(3):251-260. PubMed ID: 33858297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-26a suppresses the malignant biological behaviors of papillary thyroid carcinoma by targeting ROCK1 and regulating PI3K/AKT signaling pathway.
    Wu YC; Li SY; Jia YF
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8940-8949. PubMed ID: 31696481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long non-coding RNA TTN-AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR-153-3p/ZNRF2 axis.
    Cui Z; Luo Z; Lin Z; Shi L; Hong Y; Yan C
    J Gene Med; 2019 May; 21(5):e3083. PubMed ID: 30811764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circular RNA circ_0062389 modulates papillary thyroid carcinoma progression via the miR-1179/high mobility group box 1 axis.
    Wang Y; Zong H; Zhou H
    Bioengineered; 2021 Dec; 12(1):1484-1494. PubMed ID: 33926347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptomic signature associated with carcinogenesis and aggressiveness of papillary thyroid carcinoma.
    Teng H; Mao F; Liang J; Xue M; Wei W; Li X; Zhang K; Feng D; Liu B; Sun Z
    Theranostics; 2018; 8(16):4345-4358. PubMed ID: 30214625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exosomal circular RNA hsa_circ_007293 promotes proliferation, migration, invasion, and epithelial-mesenchymal transition of papillary thyroid carcinoma cells through regulation of the microRNA-653-5p/paired box 6 axis.
    Lin Q; Qi Q; Hou S; Chen Z; Jiang N; Zhang L; Lin C
    Bioengineered; 2021 Dec; 12(2):10136-10149. PubMed ID: 34866540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BGL3 inhibits papillary thyroid carcinoma progression via regulating PTEN stability.
    Zhao M; Yang F; Sang C; Yan C; Wang Z
    J Endocrinol Invest; 2021 Oct; 44(10):2165-2174. PubMed ID: 33543443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CRLF1 promotes malignant phenotypes of papillary thyroid carcinoma by activating the MAPK/ERK and PI3K/AKT pathways.
    Yu ST; Zhong Q; Chen RH; Han P; Li SB; Zhang H; Yuan L; Xia TL; Zeng MS; Huang XM
    Cell Death Dis; 2018 Mar; 9(3):371. PubMed ID: 29515111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.